Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

Are temporal trends in colonoscopy among young adults concordant with colorectal cancer incidence?

Fedewa SA, Siegel RL, Jemal A.

J Med Screen. 2019 Jul 11:969141319859608. doi: 10.1177/0969141319859608. [Epub ahead of print] No abstract available.

PMID:
31296103
2.

Breast cancer subtypes among Eastern-African-born black women and other black women in the United States.

Sung H, DeSantis CE, Fedewa SA, Kantelhardt EJ, Jemal A.

Cancer. 2019 Oct 1;125(19):3401-3411. doi: 10.1002/cncr.32293. Epub 2019 Jun 13.

PMID:
31190337
3.

State variation in early-onset colorectal cancer in the United States, 1995-2015.

Siegel RL, Medhanie GA, Fedewa SA, Jemal A.

J Natl Cancer Inst. 2019 May 29. pii: djz098. doi: 10.1093/jnci/djz098. [Epub ahead of print]

PMID:
31141602
4.

Changes in Breast and Colorectal Cancer Screening After Medicaid Expansion Under the Affordable Care Act.

Fedewa SA, Yabroff KR, Smith RA, Goding Sauer A, Han X, Jemal A.

Am J Prev Med. 2019 Jul;57(1):3-12. doi: 10.1016/j.amepre.2019.02.015. Epub 2019 May 22.

PMID:
31128952
5.

The American Cancer Society 2035 challenge goal on cancer mortality reduction.

Ma J, Jemal A, Fedewa SA, Islami F, Lichtenfeld JL, Wender RC, Cullen KJ, Brawley OW.

CA Cancer J Clin. 2019 Sep;69(5):351-362. doi: 10.3322/caac.21564. Epub 2019 May 8.

6.

Trends in cervical cancer incidence rates by age, race/ethnicity, histological subtype, and stage at diagnosis in the United States.

Islami F, Fedewa SA, Jemal A.

Prev Med. 2019 Jun;123:316-323. doi: 10.1016/j.ypmed.2019.04.010. Epub 2019 Apr 16.

PMID:
31002830
7.

What Are the Public Health Effects of Dense Breast Notification Laws?

Fedewa SA.

Am J Public Health. 2019 May;109(5):660-661. doi: 10.2105/AJPH.2019.305025. No abstract available.

PMID:
30969826
8.

Current Prevalence of Major Cancer Risk Factors and Screening Test Use in the United States: Disparities by Education and Race/Ethnicity.

Goding Sauer A, Siegel RL, Jemal A, Fedewa SA.

Cancer Epidemiol Biomarkers Prev. 2019 Apr;28(4):629-642. doi: 10.1158/1055-9965.EPI-18-1169. Review.

PMID:
30944145
9.

Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening.

Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram-Baptiste D, Saslow D, Wender RC.

CA Cancer J Clin. 2019 May;69(3):184-210. doi: 10.3322/caac.21557. Epub 2019 Mar 15.

10.

Letter to the Editor Regarding "Gender Identity Disparities in Cancer Screening Behaviors".

Fedewa SA, Sauer AG, Jemal A.

Am J Prev Med. 2019 Jan;56(1):162. doi: 10.1016/j.amepre.2018.08.014. No abstract available.

PMID:
30573146
11.

Global patterns in excess body weight and the associated cancer burden.

Sung H, Siegel RL, Torre LA, Pearson-Stuttard J, Islami F, Fedewa SA, Goding Sauer A, Shuval K, Gapstur SM, Jacobs EJ, Giovannucci EL, Jemal A.

CA Cancer J Clin. 2019 Mar;69(2):88-112. doi: 10.3322/caac.21499. Epub 2018 Dec 12.

12.

A blueprint for cancer screening and early detection: Advancing screening's contribution to cancer control.

Wender RC, Brawley OW, Fedewa SA, Gansler T, Smith RA.

CA Cancer J Clin. 2019 Jan;69(1):50-79. doi: 10.3322/caac.21550. Epub 2018 Nov 19.

13.

Cancer Statistics for Hispanics/Latinos, 2018.

Miller KD, Goding Sauer A, Ortiz AP, Fedewa SA, Pinheiro PS, Tortolero-Luna G, Martinez-Tyson D, Jemal A, Siegel RL.

CA Cancer J Clin. 2018 Nov;68(6):425-445. doi: 10.3322/caac.21494. Epub 2018 Oct 4.

14.

Modifiable Failures in the Colorectal Cancer Screening Process and Their Association With Risk of Death.

Doubeni CA, Fedewa SA, Levin TR, Jensen CD, Saia C, Zebrowski AM, Quinn VP, Rendle KA, Zauber AG, Becerra-Culqui TA, Mehta SJ, Fletcher RH, Schottinger J, Corley DA.

Gastroenterology. 2019 Jan;156(1):63-74.e6. doi: 10.1053/j.gastro.2018.09.040. Epub 2018 Sep 27.

PMID:
30268788
15.

Reaching 80% human papillomavirus vaccination prevalence by 2026: How many adolescents need to be vaccinated and what are their characteristics?

Fedewa SA, Preiss AJ, Fisher-Borne M, Goding Sauer A, Jemal A, Saslow D.

Cancer. 2018 Dec 15;124(24):4720-4730. doi: 10.1002/cncr.31763. Epub 2018 Sep 26.

PMID:
30257056
16.

Educational attainment & quitting smoking: A structural equation model approach.

Goding Sauer A, Fedewa SA, Kim J, Jemal A, Westmaas JL.

Prev Med. 2018 Nov;116:32-39. doi: 10.1016/j.ypmed.2018.08.031. Epub 2018 Aug 29.

PMID:
30170014
17.

Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society.

Wolf AMD, Fontham ETH, Church TR, Flowers CR, Guerra CE, LaMonte SJ, Etzioni R, McKenna MT, Oeffinger KC, Shih YT, Walter LC, Andrews KS, Brawley OW, Brooks D, Fedewa SA, Manassaram-Baptiste D, Siegel RL, Wender RC, Smith RA.

CA Cancer J Clin. 2018 Jul;68(4):250-281. doi: 10.3322/caac.21457. Epub 2018 May 30.

18.

Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening.

Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram-Baptiste D, Saslow D, Brawley OW, Wender RC.

CA Cancer J Clin. 2018 Jul;68(4):297-316. doi: 10.3322/caac.21446. Epub 2018 May 30. Review.

19.

Higher Lung Cancer Incidence in Young Women Than Young Men in the United States.

Jemal A, Miller KD, Ma J, Siegel RL, Fedewa SA, Islami F, Devesa SS, Thun MJ.

N Engl J Med. 2018 May 24;378(21):1999-2009. doi: 10.1056/NEJMoa1715907.

20.

Timely follow-up of positive cancer screening results: A systematic review and recommendations from the PROSPR Consortium.

Doubeni CA, Gabler NB, Wheeler CM, McCarthy AM, Castle PE, Halm EA, Schnall MD, Skinner CS, Tosteson ANA, Weaver DL, Vachani A, Mehta SJ, Rendle KA, Fedewa SA, Corley DA, Armstrong K.

CA Cancer J Clin. 2018 May;68(3):199-216. doi: 10.3322/caac.21452. Epub 2018 Mar 30.

21.

Recent Patterns in Shared Decision Making for Prostate-Specific Antigen Testing in the United States.

Fedewa SA, Gansler T, Smith R, Sauer AG, Wender R, Brawley OW, Jemal A.

Ann Fam Med. 2018 Mar;16(2):139-144. doi: 10.1370/afm.2200.

22.

Treatment and survival vary by race/ethnicity in patients with anaplastic thyroid cancer.

Roche AM, Fedewa SA, Shi LL, Chen AY.

Cancer. 2018 Apr 15;124(8):1780-1790. doi: 10.1002/cncr.31252. Epub 2018 Feb 6.

23.

Racial and Ethnic Disparities in Interval Colorectal Cancer Incidence.

Fedewa SA, Flanders WD, Jemal A, Doubeni CA, Goodman M.

Ann Intern Med. 2018 Jan 2;168(1):80. doi: 10.7326/L17-0498. No abstract available.

PMID:
29297032
24.

Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States.

Islami F, Goding Sauer A, Miller KD, Siegel RL, Fedewa SA, Jacobs EJ, McCullough ML, Patel AV, Ma J, Soerjomataram I, Flanders WD, Brawley OW, Gapstur SM, Jemal A.

CA Cancer J Clin. 2018 Jan;68(1):31-54. doi: 10.3322/caac.21440. Epub 2017 Nov 21.

25.

Response.

Siegel RL, Fedewa SA, Anderson WF, Miller KD, Ma J, Rosenberg PS, Jemal A.

J Natl Cancer Inst. 2017 Aug 1;109(8). doi: 10.1093/jnci/djx100. No abstract available.

26.

Comparing cancer screening estimates: Behavioral Risk Factor Surveillance System and National Health Interview Survey.

Sauer AG, Liu B, Siegel RL, Jemal A, Fedewa SA.

Prev Med. 2018 Jan;106:94-100. doi: 10.1016/j.ypmed.2017.10.019. Epub 2017 Oct 31.

PMID:
29079098
27.

Disparities in cancer screening by occupational characteristics.

Fedewa SA, Sauer AG, DeSantis C, Siegel RL, Jemal A.

Prev Med. 2017 Dec;105:311-318. doi: 10.1016/j.ypmed.2017.10.012. Epub 2017 Oct 5.

PMID:
28987332
28.

Disparities in liver cancer occurrence in the United States by race/ethnicity and state.

Islami F, Miller KD, Siegel RL, Fedewa SA, Ward EM, Jemal A.

CA Cancer J Clin. 2017 Jul 8;67(4):273-289. doi: 10.3322/caac.21402. Epub 2017 Jun 6.

29.

Trends in Diagnosis of Gleason Score 2 Through 4 Prostate Cancer in the National Cancer Database, 1990-2013.

Gansler T, Fedewa SA, Lin CC, Amin MB, Jemal A, Ward EM.

Arch Pathol Lab Med. 2017 Dec;141(12):1686-1696. doi: 10.5858/arpa.2016-0611-OA. Epub 2017 May 30.

PMID:
28557615
30.

Racial and Ethnic Disparities in Interval Colorectal Cancer Incidence: A Population-Based Cohort Study.

Fedewa SA, Flanders WD, Ward KC, Lin CC, Jemal A, Goding Sauer A, Doubeni CA, Goodman M.

Ann Intern Med. 2017 Jun 20;166(12):857-866. doi: 10.7326/M16-1154. Epub 2017 May 23.

31.

Updated Review of Prevalence of Major Risk Factors and Use of Screening Tests for Cancer in the United States.

Sauer AG, Siegel RL, Jemal A, Fedewa SA.

Cancer Epidemiol Biomarkers Prev. 2017 Aug;26(8):1192-1208. doi: 10.1158/1055-9965.EPI-17-0219. Epub 2017 May 17. Review.

32.

Recent Patterns of Prostate-Specific Antigen Testing for Prostate Cancer Screening in the United States.

Fedewa SA, Ward EM, Brawley O, Jemal A.

JAMA Intern Med. 2017 Jul 1;177(7):1040-1042. doi: 10.1001/jamainternmed.2017.0340. No abstract available.

33.

Colorectal Cancer Screening Initiation After Age 50 Years in an Organized Program.

Fedewa SA, Corley DA, Jensen CD, Zhao W, Goodman M, Jemal A, Ward KC, Levin TR, Doubeni CA.

Am J Prev Med. 2017 Sep;53(3):335-344. doi: 10.1016/j.amepre.2017.02.018. Epub 2017 Apr 17.

34.

Cancer incidence profile in sub-Saharan African-born blacks in the United States: Similarities and differences with US-born non-Hispanic blacks.

Medhanie GA, Fedewa SA, Adissu H, DeSantis CE, Siegel RL, Jemal A.

Cancer. 2017 Aug 15;123(16):3116-3124. doi: 10.1002/cncr.30701. Epub 2017 Apr 13.

35.

Colorectal Cancer Incidence Patterns in the United States, 1974-2013.

Siegel RL, Fedewa SA, Anderson WF, Miller KD, Ma J, Rosenberg PS, Jemal A.

J Natl Cancer Inst. 2017 Aug 1;109(8). doi: 10.1093/jnci/djw322.

36.

Recent Hepatitis C Virus Testing Patterns Among Baby Boomers.

Jemal A, Fedewa SA.

Am J Prev Med. 2017 Jul;53(1):e31-e33. doi: 10.1016/j.amepre.2017.01.033. Epub 2017 Mar 8. No abstract available.

PMID:
28284746
37.

Colorectal cancer statistics, 2017.

Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RGS, Barzi A, Jemal A.

CA Cancer J Clin. 2017 May 6;67(3):177-193. doi: 10.3322/caac.21395. Epub 2017 Mar 1.

38.

Cancer screening in the United States, 2017: A review of current American Cancer Society guidelines and current issues in cancer screening.

Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram-Baptiste D, Saslow D, Brawley OW, Wender RC.

CA Cancer J Clin. 2017 Mar;67(2):100-121. doi: 10.3322/caac.21392. Epub 2017 Feb 7.

39.

Lung Cancer Screening With Low-Dose Computed Tomography in the United States-2010 to 2015.

Jemal A, Fedewa SA.

JAMA Oncol. 2017 Sep 1;3(9):1278-1281. doi: 10.1001/jamaoncol.2016.6416. No abstract available.

40.

Trends and Predictors of Chemotherapy Use among Thyroid Cancer Patients in the National Cancer Database (2004-2013).

Fedewa SA, Jemal A, Chen AY.

Eur Thyroid J. 2016 Dec;5(4):268-276. doi: 10.1159/000449379. Epub 2016 Oct 21.

41.

Fecal Immunochemical Test (FIT) for Colon Cancer Screening: Variable Performance with Ambient Temperature.

Doubeni CA, Jensen CD, Fedewa SA, Quinn VP, Zauber AG, Schottinger JE, Corley DA, Levin TR.

J Am Board Fam Med. 2016 Nov 12;29(6):672-681. doi: 10.3122/jabfm.2016.06.160060.

42.

State-Level Cancer Mortality Attributable to Cigarette Smoking in the United States.

Lortet-Tieulent J, Goding Sauer A, Siegel RL, Miller KD, Islami F, Fedewa SA, Jacobs EJ, Jemal A.

JAMA Intern Med. 2016 Dec 1;176(12):1792-1798. doi: 10.1001/jamainternmed.2016.6530.

PMID:
27775761
43.

Variations in cancer centers' use of cytology for the diagnosis of unresectable pancreatic cancer in the National Cancer Data Base.

Gansler T, Fedewa SA, Lin CC, Jemal A, Ward EM.

Cancer Cytopathol. 2016 Nov;124(11):791-800. doi: 10.1002/cncy.21757. Epub 2016 Jun 27.

44.

Association of Socioeconomic Status and Race/Ethnicity With Treatment and Survival in Patients With Medullary Thyroid Cancer.

Roche AM, Fedewa SA, Chen AY.

JAMA Otolaryngol Head Neck Surg. 2016 Aug 1;142(8):763-71. doi: 10.1001/jamaoto.2016.1051.

PMID:
27254481
45.

Comparative effectiveness of surgical and nonsurgical therapy for advanced laryngeal cancer.

Lin CC, Fedewa SA, Prickett KK, Higgins KA, Chen AY.

Cancer. 2016 Sep 15;122(18):2845-56. doi: 10.1002/cncr.30122. Epub 2016 May 31.

46.

Temporal Trends in Colorectal Cancer Screening among Asian Americans.

Fedewa SA, Sauer AG, Siegel RL, Smith RA, Torre LA, Jemal A.

Cancer Epidemiol Biomarkers Prev. 2016 Jun;25(6):995-1000. doi: 10.1158/1055-9965.EPI-15-1147. Epub 2016 Apr 8.

47.

Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities.

DeSantis CE, Siegel RL, Sauer AG, Miller KD, Fedewa SA, Alcaraz KI, Jemal A.

CA Cancer J Clin. 2016 Jul;66(4):290-308. doi: 10.3322/caac.21340. Epub 2016 Feb 22.

48.

Racial/Ethnic Differences in the Association Between Hospitalization and Kidney Transplantation Among Waitlisted End-Stage Renal Disease Patients.

Newman KL, Fedewa SA, Jacobson MH, Adams AB, Zhang R, Pastan SO, Patzer RE.

Transplantation. 2016 Dec;100(12):2735-2745.

49.

Cancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screening.

Smith RA, Andrews K, Brooks D, DeSantis CE, Fedewa SA, Lortet-Tieulent J, Manassaram-Baptiste D, Brawley OW, Wender RC.

CA Cancer J Clin. 2016 Mar-Apr;66(2):96-114. doi: 10.3322/caac.21336. Epub 2016 Jan 21. Review.

50.

Mammography Use and Physician Recommendation After the 2009 U.S. Preventive Services Task Force Breast Cancer Screening Recommendations.

Fedewa SA, de Moor JS, Ward EM, DeSantis CE, Goding Sauer A, Smith RA, Jemal A.

Am J Prev Med. 2016 May;50(5):e123-e131. doi: 10.1016/j.amepre.2015.10.010. Epub 2015 Dec 14.

PMID:
26699245

Supplemental Content

Loading ...
Support Center